• KOL
    • KOLs Community
    • Respiratory
    • Respiratory Syncytial
    • Respiratory Syncytial Virus
    • Robert M Chanock
    • Robert M Chanock

      Robert M Chanock

      Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland | From the *University of ...

       

       

      KOL Resume for Robert M Chanock

      Year
      2006

      Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

      2005

      National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

      2003

      Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA

      2002

      Epidemiology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 50, Room 6308, 50 South Drive MSC 8026, Bethesda, MD 20892-8026, USA

      2001

      Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 7 Center Drive, Bethesda, MD 20892-0720, USA

      2000

      Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA

      1999

      Laboratory of Infectious Diseases National Institute of Allergy and Infectious Diseases Bethesda, Maryland 20892-0720

      1998

      Respiratory Viruses Section, Laboratory of Infectious Diseases, NIAID, National Institutes of Health, Bethesda, Maryland, 20892-0720

      1997

      Epidemiology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

      1996

      Molecular Viral Biology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, USA.

      Respiratory Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland

      1995

      Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892-0720, USA.

      1994

      Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892, USA.

      Epidemiology Section, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892.

      1993

      Virion Systems, Inc., Rockville, Maryland 20850.

      Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892.

      1992

      Respiratory Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 7, Room 106, 9000 Rockville Pike, Bethesda, MD 20892, USA

      Department of Immunology, Scripps Research Institute, La Jolla, CA 92037.

      Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

      Biotechnology and Microbiology Division, Wyeth-Ayerst Research, Philadelphia, Pennsylvania 19101.

      1991

      Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032.

      National Institutes of Health, Bethesda, MD, USA

      1990

      Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA

      Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032

      1989

      The Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA

      Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032.

      1988

      Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814.

      Laboratory of Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892.

      1987

      The Laboratory of Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA

      1986

      From the Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health (GAP, RMC), and the Uniformed Services University of the Health Sciences (VGH), Bethesda, MD.

      Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA

      1985

      Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Disease, Bethesda, Maryland 20205, USA

      1984

      Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA

      Department of Pediatrics, NIAID, National Institutes of Health, Uniformed Services University, Bethesda, MD

      1983

      Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20205, USA

      1982

      Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases Bethesda, Maryland 20205

      1981

      Laboratory of Infectious Diseases National Institute of Allergy and Infectious Disease National Institutes of Health Bethesda, Maryland 20205

      1980

      Center for Disease Control, Atlanta, Georgia 30333, U. S. A.

      George Washington University, Washington, D. C. 20052, USA

      Laboratory of Infectious Diseases National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda, Maryland 20205

      1979

      Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20014

      1978

      NIAID, Bethesda, Md

      Children's Hospital National Medical Center, George Washington Un., Washington, D.C.

      National Institute of Allergy and Infectious Diseases, Rockville, Maryland

      Department of Veterinary Science, University of Nebraska, Lincoln, Nebraska 68508, USA

      1977

      Department of Child Health and Development, George Washington University School of Medicine and Health Care Sciences, Washington, D. C. USA

      1976

      Laboratory of Infectious Diseases, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20014 USA

      1975

      the Molecular Anatomy Program, Oak Ridge National Laboratory, 5640 Fishers Lane, Rockville, Maryland, USA

      LOBUND LABORATORY, UNIVERSITY OF NOTRE DAME, NOTRE DAME, INDIANA

       

       

      Robert M Chanock: Influence Statistics

      Sample of concepts for which Robert M Chanock is among the top experts in the world.
      Concept World rank
      sharp outbreak #1
      monkeys illness #1
      infection incidence infections #1
      26 virulence #1
      pneumoniae membranes antibody #1
      density virion #1
      3 pulmonis type #1
      contacts young patients #1
      haptens mycoplasma #1
      vp7 genes strain #1
      norwalk virus proteins #1
      translation ns2 mrna #1
      respiratorytract disease #1
      virulence human influenza #1
      bronchopneumonia cent #1
      2 clones ability #1
      radioimmunoassay blocking #1
      rsv infection findings #1
      human myxoviruses #1
      neutralizing antibody vp7 #1
      rsv vaccinees #1
      chanock #1
      asymptomatic rotaviruses #1
      viruses hybridization #1
      microtiter solid phase #1
      convalescent antiserum sandoglobulin #1
      gastroenteritis wide variety #1
      local site inoculation #1
      hrvla stools #1
      infection reassortant #1
      regions vp3 #1
      human reoviruslike #1
      infectivity cell cultures #1
      microtiter solidphase detection #1
      vaccinees parainfluenza #1
      pulmonary virus height #1
      guinea pigs insect #1
      safety antigenicity #1
      specificity vp3 #1
      mycoplasma pneumoniae antigenicity #1
      ts1 wildtype virus #1
      2 20 microliter #1
      4 neutralization specificity #1
      vp3 st3 virus #1
      antibody influenzal neuraminidase #1
      symptomatic human rotavirus #1
      phosphatidylglycerol glycolipids #1
      inactivated rhinovirus #1
      bacteria bacterial genetics #1
      type 21 virus #1

       

      Prominent publications by Robert M Chanock

      KOL-Index: 20714

      In studies conducted in the 1960s, children previously immunized with a formalin-inactivated respiratory syncytial virus (RSV) vaccine (FI-RSV) developed a greater incidence and severity of pulmonary disease during subsequent natural RSV infection than did controls. It was previously shown that cotton rats immunized with FI-RSV or immunoaffinity-purified fusion (F) glycoprotein developed enhanced pulmonary histopathology following intranasal challenge with RSV. In the present studies, ...

      Known for Cotton Rats | Viral Antigens | Rsv Challenge | Enhanced Pulmonary | Animals Antibodies
      KOL-Index: 17334

      cDNA clones representing the VP4 gene of symptomatic human rotavirus strain KU (VP7 serotype 1) or DS-1 (VP7 serotype 2) or asymptomatic human rotavirus strain 1076 (VP7 serotype 2) were constructed and inserted into a baculovirus expression vector under the control of the polyhedrin promoter. The resulting recombinants expressed the appropriate authentic VP4 rotavirus outer capsid protein. Guinea pigs immunized with these VP4 proteins developed antibodies that neutralized infectivity of ...

      Known for Human Rotaviruses | Vp4 Serotype | Outer Capsid | Antigenic Relationships | Rotavirus Vp7
      KOL-Index: 16876

      Three antigenic chimeric live attenuated tick-borne encephalitis virus (TBEV) vaccine candidates were compared for level of replication in murine and human neuroblastoma cells, for neurovirulence and neuroinvasiveness in mice, and for safety, immunogenicity and efficacy in rhesus monkeys. Two chimeric viruses were generated by replacing the membrane precursor and envelope protein genes of dengue type 4 virus (DEN4) with the corresponding genes of a Far Eastern TBEV, Sofjin strain, in the ...

      Known for Rhesus Monkeys | Lgt Den4 | Borne Encephalitis | Neuroinvasiveness Mice | Virus Vaccines
      KOL-Index: 16013

      The dengue type 4 virus (DEN4) genome contains a 384-nucleotide (nt) 3' noncoding sequence in which the last 81 nt, predicted to form a secondary structure, are thought to be essential for virus replication. Immediately upstream of the secondary structure, short RNA sequences that are conserved among mosquito-borne flaviviruses have been identified. A series of deletions that range from 30 to 262 nt were introduced into this upstream region of full-length DEN4 cDNA to create viable ...

      Known for Dengue Type | Rhesus Monkeys | Rna Genome | Cell Culture | Deletion Mutants
      KOL-Index: 15875

      Within the past few years, rotavirus strains were recovered from four discrete prolonged outbreaks of infection in newborn nurseries in which affected infants failed to develop significant symptoms. The virus strains recovered from each outbreak belonged to a different human rotavirus serotype and thus each of the four human rotavirus serotypes was associated with asymptomatic infection of neonates. Marked conservation of sequence was observed among the fourth genes of the nursery ...

      Known for Amino Acid | Cleavage Region | Capsid Protein | Viral Humans Infant | Rotaviruses Recovered
      KOL-Index: 15344

      The serum antibody response of infants and children immunized with Formalin-inactivated respiratory syncytial virus (RSV) vaccine 20 years ago was determined by using an enzyme-linked immunosorbent assay specific for the RSV fusion (F) and large (G) glycoproteins and a neutralization assay. Twenty-one young infants (2 to 6 months of age) developed a high titer of antibodies to the F glycoprotein but had a poor response to the G glycoprotein. Fifteen older individuals (7 to 40 months of ...

      Known for Antibody Response | Inactivated Respiratory | Viral Child | Neutralizing Antibodies | Syncytial Virus
      KOL-Index: 14994

      In young infants who possess maternally derived respiratory syncytial virus (RSV) antibodies, the antibody response to RSV glycoproteins is relatively poor, despite extensive replication of RSV. In the present study, it was found that cotton rat RSV hyperimmune antiserum suppressed the antibody response to the RSV glycoproteins but not the response to vaccinia virus antigens when the antiserum was passively transferred to cotton rats prior to infection with vaccinia recombinant viruses ...

      Known for Immune Response | Vaccinia Virus | Respiratory Syncytial | Viral Antigens | Rsv Fusion
      KOL-Index: 14543

      A cDNA clone representing the mRNA coding sequence of the fusion glycoprotein (F) gene of human respiratory syncytial virus (RSV) was constructed and inserted into the thymidine kinase gene of vaccinia virus (WR strain) under the control of a vaccinia virus promoter. The resulting recombinant vaccinia virus, vaccinia F, expressed the F1 and F2 cleavage products (48 and 20 kDa, respectively) of the F glycoprotein in cell culture. F1 and F2 were indistinguishable from their authentic RSV ...

      Known for Vaccinia Virus | Individual Contributions | Respiratory Syncytial | Fusion Glycoprotein | Cotton Rats
      KOL-Index: 14307

      A series of reassortants was isolated from coinfection of cell cultures with wild-type bovine rotavirus (UK strain [serotype 6]) or rhesus rotavirus (strain MMU18006 [serotype 3]) and a tissue culture-adapted human rotavirus strain, ST3 (serotype 4). Monospecific antiserum or a set of monoclonal antibodies to the major outer capsid neutralization glycoprotein, VP7, of the animal rotavirus parent was used to select for reassortants with human rotavirus serotype 4 neutralization ...

      Known for Rotavirus Reassortants | Serotype 4 | Gene Substitution | Neutralization Protein | Tissue Culture
      KOL-Index: 14171

      Previously, the influenza A/Hong Kong/68-ts-1[E] virus and its recombinants (38° shutoff temperature of plaque formation) were shown to be insufficiently attenuated for persons who lacked immunity to both the hemagglutinin and neuraminidase surface glycoproteins, i.e., doubly seronegative individuals. To meet the need for immunization of such individuals, a virus more defective than the ts-1[E] recombinants was produced. The resulting virus, designated Udorn/72-ts-1A2, possessed is ...

      Known for Influenza Virus | Surface Antigens | Nasal Turbinates | Udorn 72 | Replication Vivo
      KOL-Index: 14082

      Expression of dengue virus gene products involves specific proteolytic cleavages of a precursor polyprotein. To study the flanking sequences required for expression of the dengue virus nonstructural glycoprotein NS1, we constructed a series of recombinant vaccinia viruses that contain the coding sequence for NS1 in combination with various lengths of upstream and downstream sequences. The NS1 products expressed by these viruses in infected CV-1 cells were immune precipitated and analyzed ...

      Known for Virus Nonstructural | Ns1 Ns2a | Signal Sequence | Proper Processing | Glycosylation Humans
      KOL-Index: 13906

      Respiratory syncytial virus (RSV) is the most common cause of viral bronchiolitis and pneumonia in children. The present study compares the level of attenuation, genetic stability and efficacy of three conditional-lethal temperature-sensitive (ts) mutants of the RSV A2 wild-type virus, designated ts-1, ts-1-NG1, and ts-4, in seronegative chimpanzees and also compares their efficacy with that of vaccinia virus recombinants that express the surface glycoproteins of RSV. Each of the ts ...

      Known for Attenuated Respiratory | Vaccinia Virus | Rsv Mutants | Viral Vaccines | Surface Glycoproteins
      KOL-Index: 13876

      An avian influenza A virus, A/Mallard/NY/6750/78(H2N2), was restricted in in replication in the respiratory tract of squirrel monkeys. Avian-human influenza A reassortant viruses possessing the six RNA segments coding for nonsurface proteins (i.e., internal genes) of this avian virus were as restricted in replication in squirrel monkeys as their avian influenza parent. These findings indicated that restriction of replication of the avian influenza virus is a function of one or more of ...

      Known for Respiratory Tract | Avian Influenza | Virus Replication | Internal Genes | Squirrel Monkeys
      KOL-Index: 13871

      Ten serologically distinct avian influenza A viruses were administered to squirrel monkeys and hamsters to compare their replication and virulence with those of human influenza A virus, A/Udorn/307/72 (H3N2). In squirrel monkeys, the 10 avian influenza A viruses exhibited a spectrum of replication and virulence. The levels of virus replication and clinical response were closely correlated. Two viruses, A/Mallard/NY/6874/78 (H3N2) and A/Pintail/Alb/121/79 (H7N8), resembled the human virus ...

      Known for Avian Influenza | Squirrel Monkeys | Virus Replication | Udorn 307 72 | Viral Plaque
      KOL-Index: 13747

      A formalin-inactivated respiratory syncytial virus (RSV) vaccine tested 22 years ago failed to protect infant vaccinees against RSV infection or disease. Instead, lower respiratory tract disease was enhanced during subsequent infection by RSV. Enhancement of pulmonary pathology is also observed when cotton rats are immunized with formalin-inactivated RSV and subsequently infected with this virus. A major question that must be addressed for each new paramyxovirus vaccine is whether the ...

      Known for Cotton Rats | Rsv Challenge | Viral Antigens | Cytotoxic Vaccines | Pulmonary Pathology

      Key People For Respiratory Syncytial Virus

      Top KOLs in the world
      #1
      Larry J Anderson
      respiratory syncytial virus united states monoclonal antibodies
      #2
      Caroline Breese Hall
      respiratory syncytial virus young children united states
      #3
      Edward E Walsh
      respiratory syncytial virus rsv infection monoclonal antibodies
      #4
      Eric A F SIMOES†
      respiratory syncytial virus young children preterm infants
      #5
      PETER FARNUM Wright
      influenza virus young children respiratory syncytial
      #6
      Peter L Collins
      respiratory syncytial parainfluenza virus rna replication

      Robert M Chanock:Expert Impact

      Concepts for whichRobert M Chanockhas direct influence:Respiratory syncytial virus,  Influenza virus,  Respiratory syncytial,  Syncytial virus,  Mycoplasma pneumoniae,  Eaton agent,  Cotton rats,  Human rotavirus.

      Robert M Chanock:KOL impact

      Concepts related to the work of other authors for whichfor which Robert M Chanock has influence:Respiratory syncytial,  Influenza virus,  Monoclonal antibodies,  Mycoplasma pneumoniae,  Rsv infection,  Young children,  Cotton rats.


       

      Tools

      Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile


      Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland | From the *University of Tampere Medical School, Tampere, Finland; †Wyeth Vaccines Research, Henriett

    Download on the App StoreGet it on Google Play

    Copyright © 2023 - KOL means Key Opinion Leaders .

    KOL does not provide medical advice, diagnosis or treatment.